LEF1 and hepatocellular carcinoma: Contrary to its canonical role in the Wnt/β‐catenin signaling, LEF1 has been found to directly bind to promoter regions and potentially activate key members of the NOTCH signaling pathway in hepatocellular carcinoma, enhancing self‐renewal capacity, drug resistance, dedifferentiation, and invasion [24].